Cap On Stent Prices Delayed Yet Again
In what may lead to a delay in price regulation of stents yet again, the department of pharmaceuticals (DoP) has raised objections to health ministry's proposal to cap prices of such essential medical devices.
In a fresh letter to the health ministry, the DoP, which essentially looks at production, availability and pricing of pharmaceutical products, including medical devices, has said that the industry should be given a chance for "self-regulation", before the government steps in with price control measures.
In a fresh letter to the health ministry, the DoP, which essentially looks at production, availability and pricing of pharmaceutical products, including medical devices, has said that the industry should be given a chance for "self-regulation", before the government steps in with price control measures.